Symbol Name ID |
Hepacam
hepatocyte cell adhesion molecule MGI:1920177 |
Darker colors indicate more annotations |
Human Phenotypes | Dysphagia |
Lower limb spasticity |
Upper limb spasticity |
Ventriculomegaly |
Diffuse swelling of cerebral white matter |
Diffuse white matter abnormalities |
Cerebral atrophy |
Megalencephaly |
Cerebellar atrophy |
Ataxia |
Clumsiness |
Absent speech |
Delayed speech and language development |
Dysarthria |
Mental deterioration |
Progressive neurologic deterioration |
Intellectual disability |
Motor delay |
Seizure |
Disease(s) Associated with HEPACAM | |||||||||||||||||||
megalencephalic leukoencephalopathy with subcortical cysts 2A | |||||||||||||||||||
megalencephalic leukoencephalopathy with subcortical cysts 2B |
Mouse Phenotypes | cerebral edema |
increased brain size |
brain vacuoles |
abnormal astrocyte morphology |
abnormal myelin sheath morphology |
abnormal glial cell physiology |
abnormal oligodendrocyte physiology |
|
Availability | Mouse Genotype | |||||||
Hepacamtm1.1Tjj/Hepacamtm1.1Tjj | ||||||||
Hepacamtm1.2Tjj/Hepacamtm1.2Tjj | ||||||||
Hepacamtm1Vlcg/Hepacamtm1Vlcg | ||||||||
Hepacamtm1.1Tjj/Hepacam+ |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 05/21/2024 MGI 6.23 |
|
|